Avanir Divests FazaClo To Azur Pharma To Fund Zenvia Studies
Azur Pharma will pay $42 million up front to acquire the schizophrenia medication and commercial infrastructure.
Azur Pharma will pay $42 million up front to acquire the schizophrenia medication and commercial infrastructure.